Literature DB >> 15896906

Upregulation of the phosphorylated form of CREB in spinothalamic tract cells following spinal cord injury: relation to central neuropathic pain.

E D Crown1, Z Ye, K M Johnson, G-Y Xu, D J McAdoo, K N Westlund, C E Hulsebosch.   

Abstract

Spinal cord injury (SCI) often leads to the generation of chronic intractable neuropathic pain. The mechanisms that lead to chronic central neuropathic pain (CNP) following SCI are not well understood, resulting in ineffective treatments for pain relief. Studies have demonstrated persistent hyperexcitability of dorsal horn neurons which may provide a substrate for CNP. We propose a number of similarities between CNP mechanisms and mechanisms that occur in long-term potentiation, in which hippocampal neurons are hyperexcitable. One biochemical similarity may be activation of the transcription factor, cyclic AMP response element-binding protein (CREB), via phosphorylation (pCREB). The current study was designed to examine whether tactile allodynia that develops in segments rostral to SCI (at-level pain) correlates with an increase in CREB phosphorylation in specific neurons known to be involved in allodynia, the spinothalamic tract (STT) cells. This study determined that, in animals experiencing at-level allodynia 35 days after SCI, pCREB was upregulated in the spinal cord segment rostral to the injury. In addition, pCREB was found to be upregulated specifically in STT cells in the rostral segment 35 days after SCI. These findings suggest one mechanism of maintained central neuropathic pain following SCI involves persistent upregulation of pCREB expression within STT cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896906     DOI: 10.1016/j.neulet.2005.04.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Co-localization of p-CREB and p-NR1 in spinothalamic neurons in a chronic muscle pain model.

Authors:  Marie K Hoeger Bement; Kathleen A Sluka
Journal:  Neurosci Lett       Date:  2007-03-12       Impact factor: 3.046

2.  Segmental neuropathic pain does not develop in male rats with complete spinal transections.

Authors:  Charles H Hubscher; Ezidin G Kaddumi; Richard D Johnson
Journal:  J Neurotrauma       Date:  2008-10       Impact factor: 5.269

3.  Sex and hormonal variations in the development of at-level allodynia in a rat chronic spinal cord injury model.

Authors:  Charles H Hubscher; Jason D Fell; Daya S Gupta
Journal:  Neurosci Lett       Date:  2010-04-29       Impact factor: 3.046

4.  Calcium/calmodulin-dependent protein kinase IV mediates acute nicotine-induced antinociception in acute thermal pain tests.

Authors:  Kia J Jackson; Mohamad I Damaj
Journal:  Behav Pharmacol       Date:  2013-12       Impact factor: 2.293

5.  Chronic at- and below-level pain after moderate unilateral cervical spinal cord contusion in rats.

Authors:  Megan Ryan Detloff; Rodel E Wade; John D Houlé
Journal:  J Neurotrauma       Date:  2013-05-15       Impact factor: 5.269

6.  Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury.

Authors:  Eric D Crown; Young Seob Gwak; Zaiming Ye; Kathia M Johnson; Claire E Hulsebosch
Journal:  Exp Neurol       Date:  2008-06-12       Impact factor: 5.330

Review 7.  Opioid administration following spinal cord injury: implications for pain and locomotor recovery.

Authors:  Sarah A Woller; Michelle A Hook
Journal:  Exp Neurol       Date:  2013-03-15       Impact factor: 5.330

Review 8.  Mechanisms of chronic central neuropathic pain after spinal cord injury.

Authors:  Claire E Hulsebosch; Bryan C Hains; Eric D Crown; Susan M Carlton
Journal:  Brain Res Rev       Date:  2008-12-25

9.  Aquaporin 1 - a novel player in spinal cord injury.

Authors:  O Nesic; J Lee; G C Unabia; K Johnson; Z Ye; L Vergara; C E Hulsebosch; J R Perez-Polo
Journal:  J Neurochem       Date:  2008-01-28       Impact factor: 5.372

10.  Modelling at-level allodynia after mid-thoracic contusion in the rat.

Authors:  Gary H Blumenthal; Bharadwaj Nandakumar; Ashley K Schnider; Megan R Detloff; Jerome Ricard; John R Bethea; Karen A Moxon
Journal:  Eur J Pain       Date:  2021-01-25       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.